Regulation of Hippo/YAP signaling pathway ameliorates cochlear hair cell injury by regulating ferroptosis

被引:8
|
作者
Niu, Xiaorong [1 ]
Han, Peng [1 ]
Liu, Junsong [1 ]
Chen, Zichen [2 ]
Ma, Xiaoyan [1 ]
Zhang, Ting [1 ]
Li, Baiya [1 ]
Ma, Xudong [3 ,4 ]
机构
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Otorhinolaryngol Head & Neck Surg, Xian 710061, Shaanxi, Peoples R China
[2] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Otorhinolaryngol Head & Neck Surg, Xian 710004, Shaanxi, Peoples R China
[3] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Neurosurg, Xian 710061, Shaanxi, Peoples R China
[4] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Neurosurg, 227 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China
关键词
YAP; Cochlear hair cell; Ferroptosis; Transferrin receptor; Ferritin light chain; CISPLATIN-INDUCED OTOTOXICITY; AUTOPHAGY; VERTEPORFIN; SENSITIVITY; EXPRESSION; TRANSPORT; DEATH;
D O I
10.1016/j.tice.2023.102051
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Cisplatin, which is effective for the treatment of solid tumors, also can induce cochlear hair cell damage. Therefore, this study was intended to explore how Hippo/YAP signaling pathway affects the cochlear hair cell injury by regulating ferroptosis. After cisplatin induction, or LAT1-IN-1 (YAP activator) and verteporfin (YAP inhibitor) treatment or transfection, the viability of HEI-OC1 cells was detected by cell counting kit-8 (CCK-8) assay. The iron level and the levels of oxidative stress markers (ROS, MDA and 4-HNE) were analyzed by iron assay kit, reactive oxygen species (ROS), malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE) assay kits, respectively. The expression of ferritin light chain (FTL) in HEI-OC1 cells was detected by immunofluorescence and protein expressions of yes associated protein (YAP,) phosphorylated YAP (p-YAP), transferrin receptor (TFRC), glutathione peroxidase 4 (GPX4), acyl-CoA synthetase long-chain family member 4 (ACSL4) and solute carrier family 7 member 11 (SLC7A11) in HEI-OC1 cells were detected by western blot. The transcription of FTL and TFRC by YAP1 was verified by dual-luciferase reporter assay. The transfection efficiency of small interfering RNA (si-RNA) specific to FTL (siRNA-FTL) and TFRC (siRNA-TFRC) was confirmed by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). As a result, cisplatin inhibited the viability of HEIOC1 cells by increasing free Fe2+ level and decreasing FTL level. LAT1-IN-1 promoted the viability of cisplatininduced HEI-OC1 cells by suppressing oxidative stress level, free Fe2+ level, ferroptosis and increasing FTL level, while the effect of verteporfin was the opposite. YAP1 transcriptionally regulated the expression of FTL and TFRC. Inhibition of FTL suppressed the viability of cisplatin-induced HEI-OC1 cells by increasing oxidative stress level, free Fe2+ level, ferroptosis and decreasing FTL level, while the effect of TFRC inhibition was the opposite. In conclusion, YAP1 ameliorated cochlear hair cell injury by upregulating FTL and TFRC to suppress ferroptosis.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Tetramethylpyrazine Ameliorates Peritoneal Angiogenesis by Regulating VEGF/Hippo/YAP Signaling
    Zhu, Xiaolin
    Shan, Yun
    Yu, Manshu
    Shi, Jun
    Tang, Lei
    Cao, Huimin
    Sheng, Meixiao
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [2] Doxofylline ameliorates liver fibrosis by regulating the ferroptosis signaling pathway
    Xu, Lenan
    Zhang, Meiling
    Pan, Junzhi
    Xu, Xiangwei
    Zhang, Yawen
    Han, Xue
    Yin, Lina
    Chen, Lingfeng
    Ren, Juan
    Yu, Jie
    Zhang, Yanmei
    Liang, Guang
    Zhang, Yi
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [3] Regulation of ferroptosis in cancer cells by YAP/TAZ and Hippo pathways: The therapeutic implications
    Sun, Tianai
    Chi, Jen-Tsan
    GENES & DISEASES, 2021, 8 (03) : 241 - 249
  • [4] Magnesium isoglycyrrhizinate ameliorates liver fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway
    Sui, Miao
    Jiang, Xiaofei
    Chen, Jun
    Yang, Haiyan
    Zhu, Yan
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 106 : 125 - 133
  • [5] Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance
    Wang, Dong-Yu
    Wu, Ya-Nan
    Huang, Jun-Qi
    Wang, Wei
    Xu, Meng
    Jia, Jin-Peng
    Han, Gang
    Mao, Bei-Bei
    Bi, Wen-Zhi
    CHINESE JOURNAL OF CANCER, 2016, 35 : 1 - 8
  • [6] Hippo/YAP signaling pathway protects against neomycin-induced hair cell damage in the mouse cochlea
    Wang, Maohua
    Dong, Ying
    Gao, Song
    Zhong, Zhenhua
    Cheng, Cheng
    Qiang, Ruiying
    Zhang, Yuhua
    Shi, Xinyi
    Qian, Xiaoyun
    Gao, Xia
    Guan, Bing
    Yu, Chenjie
    Yu, Youjun
    Chai, Renjie
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2022, 79 (02)
  • [7] Hippo pathway effectors YAP/TAZ as novel determinants of ferroptosis
    Yang, Wen-Hsuan
    Chi, Jen-Tsan
    MOLECULAR & CELLULAR ONCOLOGY, 2020, 7 (01)
  • [8] CYLD regulates cell ferroptosis through Hippo/YAP signaling in prostate cancer progression
    Gu, Yanan
    Wu, Shiqi
    Fan, Junjie
    Meng, Zeji
    Gao, Guoqiang
    Liu, Tianjie
    Wang, Qi
    Xia, Huayu
    Wang, Xinyang
    Wu, Kaijie
    CELL DEATH & DISEASE, 2024, 15 (01)
  • [9] Regulation of PPARγ/CPT-1 expression ameliorates cochlear hair cell injury by regulating cellular lipid metabolism and oxidative stress
    Niu, Xiaorong
    Han, Peng
    Liu, Junsong
    Chen, Zichen
    Zhang, Ting
    Li, Baiya
    Ma, Xiaoyan
    Wu, Qun
    Ma, Xudong
    MOLECULAR GENETICS AND GENOMICS, 2023, 298 (02) : 473 - 483
  • [10] Regulation of PPARγ/CPT-1 expression ameliorates cochlear hair cell injury by regulating cellular lipid metabolism and oxidative stress
    Xiaorong Niu
    Peng Han
    Junsong Liu
    Zichen Chen
    Ting Zhang
    Baiya Li
    Xiaoyan Ma
    Qun Wu
    Xudong Ma
    Molecular Genetics and Genomics, 2023, 298 : 473 - 483